InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
3
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-37.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Chevallard Daniel R., 首席财务官. Insider active across 3 companies, notably Viracta Therapeutics, Inc.. In total, 16 disclosures have been recorded. Split: 3 buys · 1 sell. Total volume traded: €104k. History available since 28 May 2021. The latest transaction was filed on 27 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chevallard Daniel R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
7,500 股@ US$8.5754.7% 占其流量Common StockSEC:0001706176-26-000004:0
标准退出：2026年6月25日 (T+90)
20 股@ US$22.710.4% 占其流量Common StockSEC:0001815776-25-000072:0
标准退出：2026年2月5日 (T+90)
3,188 股@ US$15.68100.0% 占其流量Common StockSEC:0001815776-24-000046:0
标准退出：2024年8月12日 (T+90)
6,889 股0Common StockSEC:0001209191-24-004037:0
3,720 股@ US$0.509.3% 占其流量Common StockSEC:0001209191-23-056842:1
6,889 股0Common StockSEC:0001209191-23-056842:0
6,888 股0Common StockSEC:0001209191-23-047665:0
6,889 股0Common StockSEC:0001209191-23-032707:0
6,889 股0Common StockSEC:0001209191-23-013854:0
6,889 股0Common StockSEC:0001209191-22-058981:0
6,889 股0Common StockSEC:0001209191-22-047948:0
6,889 股0Common StockSEC:0001209191-22-032665:0
6,889 股0Common StockSEC:0001209191-22-014438:0
13,777 股0Common StockSEC:0001209191-21-067045:0
10,000 股@ US$0.9042.2% 占其流量Common StockSEC:0001209191-21-058099:0
12,000 股@ US$0.9048.5% 占其流量Common StockSEC:0001209191-21-036907:0
16 条申报中的 16 条
About Chevallard Daniel R.
Chevallard Daniel R. is Directeur Financier. He has 16 filings in total. In the recent sampled filings we hold, buys total EUR 102337 and sells total EUR 1697, over the period from 2021-06-01 to 2026-03-30. The companies cited are Viracta Therapeutics, Inc. and LENZ Therapeutics, Inc., and the most frequent transaction nature is Levée d'options.
